Edward M. Kaye
2013 - Sarepta Therapeutics
In 2013, Edward M. Kaye earned a total compensation of $2.6M as Interim Chief Executive Officer, and Senior Vice President, Chief Medical Officer at Sarepta Therapeutics, a 130% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $167,213 |
|---|---|
| Option Awards | $2,086,290 |
| Salary | $377,650 |
| Other | $17,797 |
| Total | $2,648,950 |
Kaye received $2.1M in option awards, accounting for 79% of the total pay in 2013.
Kaye also received $167.2K in non-equity incentive plan, $377.7K in salary and $17.8K in other compensation.
Rankings
In 2013, Edward M. Kaye's compensation ranked 2,927th out of 12,286 executives tracked by ExecPay. In other words, Kaye earned more than 76.2% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 2,927 out of 12,286 | 76th |
Division Manufacturing | 971 out of 4,612 | 79th |
Major group Chemicals And Allied Products | 255 out of 1,466 | 83rd |
Industry group Drugs | 173 out of 1,160 | 85th |
Industry Pharmaceutical Preparations | 143 out of 890 | 84th |
Source: SEC filing on May 31, 2016.
Kaye's colleagues
We found four more compensation records of executives who worked with Edward M. Kaye at Sarepta Therapeutics in 2013.